Business Context and Reporting Period
This Form 8-K is a current report filed by Renovaro Inc. (trading symbol: RENB) on September 12, 2024. The filing addresses a regulatory notice received from The Nasdaq Stock Market regarding the company's continued listing status. Note: The request metadata references "Lunai Bioworks Inc.", but the filing text explicitly identifies the registrant as Renovaro Inc.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on compliance with listing standards.
Material Changes
The material event reported is the receipt of a deficiency notice from Nasdaq. The company's common stock failed to comply with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This non-compliance was based on the closing bid price for the 30 consecutive business days prior to the notice date.
Guidance, Outlook, and Risks
- Compliance Timeline: The company has an initial compliance period of 180 calendar days, ending on March 11, 2025.
- Remediation Requirement: To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to the March 11, 2025 deadline.
- Secondary Compliance Period: If the company fails to meet the initial deadline, it may be eligible for an additional 180-day period, provided it meets other listing standards (e.g., market value of publicly held shares) and notifies Nasdaq of its intent to cure.
- Delisting Risk: Failure to qualify for or succeed in the second compliance period will result in a delisting determination, which the company may appeal to a Hearings Panel.
- Management Action: Management intends to monitor the stock price and is considering options to regain compliance.
Investor Verification Checklist
- Verify the current trading price of RENB to assess the gap from the $1.00 threshold.
- Monitor the company's stock price trajectory over the next 180 days to determine if the 10-day consecutive trading requirement can be met.
- Check for any future announcements regarding reverse stock splits or other corporate actions intended to raise the share price.
- Review the company's market value of publicly held shares to ensure eligibility for a potential second compliance period.